Please login to the form below

Not currently logged in

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen flag

Offers prospect of lower-cost alternative to Roche's Avastin

Sandoz says Humira biosimilar clears clinical hurdle

Sandoz NovartisIts drug matches the safety and efficacy of AbbVie’s plaque psoriasis blockbuster

Lilly's abemaciclib data leaves potential uncertain

Eli Lilly HQMONARCH 3 trial showed similar results to Pfizer’s Ibrance and Novartis’ Kisqali

Novartis scores but Roche misses in melanoma trials

Novartis buildingPhase III trial combo success for Tafinlar/Mekinist “unprecedented”

Teva poaches Lundbeck's Schultz as new CEO

TevaShares in Lundbeck fall as two senior posts become vacant

Prix Galien opens for entries with new award

UK Prix Galien Awards 20122018 programme will include new medical technology category

AZ buoyed by latest lung cancer data at ESMO

ESMOData from separate Tagrisso and Imfinzi trials show superior PFS among patients

Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive

Eli Lilly HQUS drug maker to slash its workforce by 8.5%

BMS' Opdivo and Yervoy ace kidney cancer trial

Bristol-Myers Squibb (BMS) buildingCombined checkpoint inhibitors show improved survival versus standard therapy

Riding the wave of digital disruption

The challenges and rewards of meeting consumer expectations

  • Real-world evidence

    Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

  • The future of biotech

    What impact will the sector, and its R&D performance, have on pharma?

Featured jobs

Subscribe to our email news alerts


Add my company
inVentiv Health Communications

inVentiv Health Communications brings together best-in-class agencies across advertising, digital, public relations, medical communications, research, market access and clinical trial...

Latest intelligence

Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...